E-Scopics
E-Scopics is a French MedTech company specializing in the development and manufacture of ultraportable ultrasound medical devices. Their flagship product, Hepatoscope, is an ultraportable bedside ultrasound system designed for non-invasive liver assessment, including liver stiffness measurement and quantitative parameters related to liver steatosis. The system is FDA cleared and CE marked, usable on consumer laptops and tablets, and intended for use by both MD and non-MD users. Hepatoscope supports clinical applications such as diagnosis, monitoring, and management of liver diseases including MASLD, MASH, drug-induced liver injury, alcoholic liver disease, autoimmune liver disease, chronic viral hepatitis, and cholestatic liver diseases. The company operates on a software and hardware model, providing a probe and software solution that is updated regularly. E-Scopics emphasizes ease of use, real-time imaging, and reproducible quantitative measurements at the point of care, aiming to democratize liver health assessment with a portable, user-friendly device.
E-Scopics
E-Scopics is a French MedTech company specializing in the development and manufacture of ultraportable ultrasound medical devices. Their flagship product, Hepatoscope, is an ultraportable bedside ultrasound system designed for non-invasive liver assessment, including liver stiffness measurement and quantitative parameters related to liver steatosis. The system is FDA cleared and CE marked, usable on consumer laptops and tablets, and intended for use by both MD and non-MD users. Hepatoscope supports clinical applications such as diagnosis, monitoring, and management of liver diseases including MASLD, MASH, drug-induced liver injury, alcoholic liver disease, autoimmune liver disease, chronic viral hepatitis, and cholestatic liver diseases. The company operates on a software and hardware model, providing a probe and software solution that is updated regularly. E-Scopics emphasizes ease of use, real-time imaging, and reproducible quantitative measurements at the point of care, aiming to democratize liver health assessment with a portable, user-friendly device.
TL;DR
HQ: Aix-en-Provence, France
Product: Hepatoscope — ultraportable bedside ultrasound for liver assessment
Regulatory: FDA cleared (K232336) and CE marked
Team size: 19 employees (reported)
Funding: Single non-equity assistance round (Aug 2018)
Company Overview
Problem Domain
Point-of-care liver disease diagnosis, monitoring, and management (MASLD/MASH, drug- and alcohol-related liver injury, autoimmune and viral liver diseases, cholestatic diseases).
Founded
2018
Industry
MedTech
Funding Track Record
Non-dilutive assistance/grant-style support recorded on Aug 1, 2018